J, L., U, D., S, A., A, P., S, K., K, S., . . . CL, R. (2023). Performance of DNA-based biomarkers for classification of adrenocortical carcinoma: A prognostic study. European journal of endocrinology, 189(2), 262. https://doi.org/10.1093/ejendo/lvad112
Chicago Style (17th ed.) CitationJ, Lippert, et al. "Performance of DNA-based Biomarkers for Classification of Adrenocortical Carcinoma: A Prognostic Study." European Journal of Endocrinology 189, no. 2 (2023): 262. https://doi.org/10.1093/ejendo/lvad112.
MLA (9th ed.) CitationJ, Lippert, et al. "Performance of DNA-based Biomarkers for Classification of Adrenocortical Carcinoma: A Prognostic Study." European Journal of Endocrinology, vol. 189, no. 2, 2023, p. 262, https://doi.org/10.1093/ejendo/lvad112.